Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL.
Saved in:
| Title: | Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. |
|---|---|
| Authors: | Álvarez-Corrales E; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Moreno-Palomares R; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Gómez-Escolar C; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Instituto de Neurociencias de Alicante (CSIC), Alicante, Spain., Martínez M; Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain., Moral-Pérez U; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain., Laguna-Herrero M; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Fuertes T; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Pharmacy and Nutrition, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Estrada BS; Interactions with the environment program, Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid, Spain; Intestinal Morphogenesis and Homeostasis Group, Area 3-Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Mur S; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., de Bonis A; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Leiva M; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain., Martínez-Martín N; Interactions with the environment program, Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid, Spain; Intestinal Morphogenesis and Homeostasis Group, Area 3-Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Somoza Á; Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain., Ramiro AR; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., de Yébenes VG; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain. vgarciay@ucm.es.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. vgarciay@ucm.es. |
| Source: | Leukemia [Leukemia] 2026 May; Vol. 40 (5), pp. 894-905. Date of Electronic Publication: 2026 Apr 08. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Publishing Group, Specialist Journals Country of Publication: England NLM ID: 8704895 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5551 (Electronic) Linking ISSN: 08876924 NLM ISO Abbreviation: Leukemia Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41951939 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Álvarez-Corrales+E%22">Álvarez-Corrales E</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Moreno-Palomares+R%22">Moreno-Palomares R</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gómez-Escolar+C%22">Gómez-Escolar C</searchLink>; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Instituto de Neurociencias de Alicante (CSIC), Alicante, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez+M%22">Martínez M</searchLink>; Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Moral-Pérez+U%22">Moral-Pérez U</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Laguna-Herrero+M%22">Laguna-Herrero M</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Fuertes+T%22">Fuertes T</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Department of Pharmacy and Nutrition, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Estrada+BS%22">Estrada BS</searchLink>; Interactions with the environment program, Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid, Spain; Intestinal Morphogenesis and Homeostasis Group, Area 3-Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Mur+S%22">Mur S</searchLink>; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+Bonis+A%22">de Bonis A</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Leiva+M%22">Leiva M</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martínez-Martín+N%22">Martínez-Martín N</searchLink>; Interactions with the environment program, Centro de Biología Molecular Severo Ochoa (CBMSO), CSIC-UAM, Madrid, Spain; Intestinal Morphogenesis and Homeostasis Group, Area 3-Cancer, Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Somoza+Á%22">Somoza Á</searchLink>; Instituto Madrileño de Estudios Avanzados en Nanociencia (IMDEA Nanociencia), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Ramiro+AR%22">Ramiro AR</searchLink>; B Cell Biology Lab. Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22de+Yébenes+VG%22">de Yébenes VG</searchLink>; Department of Immunology, Ophthalmology and ENT, Universidad Complutense de Madrid, Madrid, Spain. vgarciay@ucm.es.; Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), Madrid, Spain. vgarciay@ucm.es. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228704895%22">Leukemia</searchLink> [Leukemia] 2026 May; Vol. 40 (5), pp. 894-905. <i>Date of Electronic Publication: </i>2026 Apr 08. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%2C+Specialist+Journals%22">Nature Publishing Group, Specialist Journals </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>8704895 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1476-5551 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2208876924%22">08876924 </searchLink><i>NLM ISO Abbreviation: </i>Leukemia <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41951939 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41375-026-02948-9 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 894 Titles: – TitleFull: Targeting of ibrutinib resistance-driving pathways by miR-28 in ABC-DLBCL. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Álvarez-Corrales E – PersonEntity: Name: NameFull: Moreno-Palomares R – PersonEntity: Name: NameFull: Gómez-Escolar C – PersonEntity: Name: NameFull: Martínez M – PersonEntity: Name: NameFull: Moral-Pérez U – PersonEntity: Name: NameFull: Laguna-Herrero M – PersonEntity: Name: NameFull: Fuertes T – PersonEntity: Name: NameFull: Estrada BS – PersonEntity: Name: NameFull: Mur S – PersonEntity: Name: NameFull: de Bonis A – PersonEntity: Name: NameFull: Leiva M – PersonEntity: Name: NameFull: Martínez-Martín N – PersonEntity: Name: NameFull: Somoza Á – PersonEntity: Name: NameFull: Ramiro AR – PersonEntity: Name: NameFull: de Yébenes VG IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 05 Text: 2026 May Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1476-5551 Numbering: – Type: volume Value: 40 – Type: issue Value: 5 Titles: – TitleFull: Leukemia Type: main |
| ResultId | 1 |